Marinol and Psoriasis - a phase IV clinical study of FDA data


We study 4,733 people who have side effects when taking Marinol. Psoriasis is found, especially among people who are female, 60+ old, also take Ambien and have Breast cancer.

The phase IV clinical study analyzes which people take Marinol and have Psoriasis. It is created by eHealthMe based on reports from the FDA, and is updated regularly. You may use the study as a second opinion to make health care decisions.

Phase IV trials are used to detect adverse drug outcomes and monitor drug effectiveness in the real world. With medical big data and AI algorithms, eHealthMe is running millions of phase IV trials and makes the results available to the public. Our original studies have been referenced on 700+ medical publications including The Lancet, Mayo Clinic Proceedings, and Nature.

On Sep, 30, 2023

4,733 people reported to have side effects when taking Marinol.
Among them, 13 people (0.27%) have Psoriasis.

What is Marinol?

Marinol has active ingredients of dronabinol. It is used in pain. Currently, eHealthMe is studying from 4,835 Marinol users.

What is Psoriasis?

Psoriasis (immune-mediated disease that affects the skin) is found to be associated with 2,535 drugs and 1,640 conditions by eHealthMe. Currently, we are studying 477,421 people who have Psoriasis.

Number of Marinol and Psoriasis reports submitted per year:

Could Marinol cause Psoriasis?

Gender of people who have Psoriasis when taking Marinol *:

  • female: 84.62 %
  • male: 15.38 %

Age of people who have Psoriasis when taking Marinol *:

  • 0-1: 0.0 %
  • 2-9: 0.0 %
  • 10-19: 8.33 %
  • 20-29: 8.33 %
  • 30-39: 8.33 %
  • 40-49: 0.0 %
  • 50-59: 0.0 %
  • 60+: 75.0 %

Common drugs people take besides Marinol *:

  1. Ambien: 11 people, 84.62%
  2. Zometa: 10 people, 76.92%
  3. Taxol: 10 people, 76.92%
  4. Glucovance: 10 people, 76.92%
  5. Glucophage: 10 people, 76.92%
  6. Faslodex: 10 people, 76.92%
  7. Exemestane: 10 people, 76.92%
  8. Oxycontin: 10 people, 76.92%
  9. Elocon: 10 people, 76.92%
  10. Cytoxan: 10 people, 76.92%

Common side effects people have besides Psoriasis *:

  1. Appetite - Decreased (decreased appetite occurs when you have a reduced desire to eat): 11 people, 84.62%
  2. Insomnia (sleeplessness): 11 people, 84.62%
  3. Wound Dehiscence (a surgical incision reopens either internally or externally): 10 people, 76.92%
  4. High Blood Cholesterol: 10 people, 76.92%
  5. Dental Fistula: 10 people, 76.92%
  6. Dizziness: 10 people, 76.92%
  7. Fractured Sacrum: 10 people, 76.92%
  8. General Physical Health Deterioration (weak health status): 10 people, 76.92%
  9. Granuloma (a small area of inflammation due to tissue injury): 10 people, 76.92%
  10. Head Injury: 10 people, 76.92%

Common conditions people have *:

  1. Fungal Infection: 10 people, 76.92%
  2. Breast Cancer: 10 people, 76.92%
  3. Depression: 2 people, 15.38%
  4. Crohn's Disease (condition that causes inflammation of the gastrointestinal tract): 2 people, 15.38%
  5. Ulcerative Colitis (inflammatory bowel disease (ibd). it causes swelling, ulcerations, and loss of function of the large intestine): 1 person, 7.69%
  6. Memory Loss: 1 person, 7.69%

* Approximation only. Some reports may have incomplete information.

Do you take Marinol and have Psoriasis?

Check whether Psoriasis is associated with a drug or a condition

How to use the study?

You can discuss the study with your doctor, to ensure that all drug risks and benefits are fully discussed and understood.

Related publications that referenced our studies

Related studies

Marinol side effects by duration, gender and age:

Psoriasis treatments and more:

Common drugs associated with Psoriasis:

All the drugs that are associated with Psoriasis:

Common conditions associated with Psoriasis:

All the conditions that are associated with Psoriasis:

How the study uses the data?

The study uses data from the FDA. It is based on dronabinol (the active ingredients of Marinol) and Marinol (the brand name). Other drugs that have the same active ingredients (e.g. generic drugs) are not considered. Dosage of drugs is not considered in the study.

Who is eHealthMe?

With medical big data and proven AI algorithms, eHealthMe provides a platform for everyone to run phase IV clinical trials. We study millions of patients and 5,000 more each day. Results of our real-world drug study have been referenced on 700+ medical publications, including The Lancet, Mayo Clinic Proceedings, and Nature. Our analysis results are available to researchers, health care professionals, patients (testimonials), and software developers (open API).


WARNING: Please DO NOT STOP MEDICATIONS without first consulting a physician since doing so could be hazardous to your health.

DISCLAIMER: All material available on is for informational purposes only, and is not a substitute for medical advice, diagnosis, or treatment provided by a qualified healthcare provider. All information is observation-only. Our phase IV clinical studies alone cannot establish cause-effect relationship. Different individuals may respond to medication in different ways. Every effort has been made to ensure that all information is accurate, up-to-date, and complete, but no guarantee is made to that effect. The use of the eHealthMe site and its content is at your own risk.

If you use this eHealthMe study on publication, please acknowledge it with a citation: study title, URL, accessed date.

Recent studies on eHealthMe: